Publications

Publications

Filter Results: (411) Arrow Down

Show Results For

← Page 3 of 411 Results →
  • 15 Mar 2021
  • Working Paper Summaries

The Health Costs of Cost-Sharing

Keywords: by Amitabh Chandra, Evan Flack, and Ziad Obermeyer
  • 13 Oct 2016
  • News

Drug Coupons: Helping a Few at the Expense of Everyone

  • 08 Nov 2016
  • News

CVS expects to lose 40 million prescriptions to Walgreens

    A Prescriptive Analytics Framework for Optimal Policy Deployment Using Heterogeneous Treatment Effects

    We define a prescriptive analytics framework that addresses the needs of a constrained decision-maker facing, ex ante, unknown costs and benefits of multiple policy levers. The framework is general in nature and can be deployed in any utility maximizing... View Details
    • Web

    Drug & Alcohol Policy | About

    alcohol. Additionally, the misuse of prescription drugs (sharing, buying, or using in a manner different than prescribed) is a violation of HBS policy. Although Massachusetts law now permits adults aged 21... View Details
    • October 2000 (Revised March 2003)
    • Case

    Merck & Company: Evaluating a Drug Licensing Opportunity

    By: Richard S. Ruback and David B Krieger
    This explores the valuation of an opportunity to license a compound before it enters clinical trials. Describes Merck's decision tree evaluation process is presented. Information required to evaluate a specific licensing opportunity is provided, including the costs of... View Details
    Keywords: Decision Making; Cost vs Benefits; Opportunities; Valuation; Outcome or Result; Pharmaceutical Industry
    Related
    • July 2019
    • Article

    The Impact of Price Regulation on the Availability of New Drugs in Germany

    By: Ariel Dora Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim and Ameet Sarpatwari
    The 2011 German Pharmaceutical Market Restructuring Act (“AMNOG”) subjected branded, non-rare disease drugs to price regulation based on an assessment of their clinical benefit. Assessment outcomes range from “major added benefit” to “less benefit than the appropriate... View Details
    Keywords: Regulation; Pharmaceuticals; Healthcare; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Germany
    Related
    • 12 Jun 2018
    • Research & Ideas

    In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?

    Papanikolaou, Kellogg School of Management. On balance, novel drugs with unproven chemical formulas are riskier to pursue because they are less likely to win approval from the US Food and Drug... View Details
    Keywords: by Rachel Layne; Health; Pharmaceutical
    • August 2012 (Revised August 2024)
    • Case

    ABC Pharmaceuticals

    By: Regina E. Herzlinger and Erik R. Sparks
    This case asks students to price a new drug that is in Stage II of its clinical trials. It contains detailed estimates of the time required and costs for all the steps needed to commercialize a drug in the U.S. Students will learn virtually all the steps required to... View Details
    Keywords: Drug Development; Price; Product; Product Launch; Health Industry; Technology Industry; Pharmaceutical Industry
    Related
    • Web

    2.3.1 Drug & Alcohol Policy | MBA

    possessing or serving alcohol. HBS holds its students, faculty, and staff responsible for the consequences of their decisions to use or distribute illicit drugs or to serve or consume alcohol. Additionally, the misuse of View Details
    • Article

    Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users

    By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt
    Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling... View Details
    Keywords: Pharmaceuticals; Drug Spending; Drug Pricing; Health Care and Treatment; Spending; Price; Markets; Cost Management; United States
    Related
    • 09 Feb 2024
    • HBS Case

    Slim Chance: Drugs Will Reshape the Weight Loss Industry, But Habit Change Might Be Elusive

    what may at first blush appear to be an easier fix: new drugs such as Ozempic, Wegovy, and Mounjaro, says Harvard Business School Professor Regina E. Herzlinger, who has studied the American health care system for decades. Wegovy has been... View Details
    Keywords: by Lane Lambert; Health; Pharmaceutical
    • 28 Mar 2023
    • Research & Ideas

    The FDA’s Speedy Drug Approvals Are Safe: A Win-Win for Patients and Pharma Innovation

    spent $83 billion on research and development (R&D) in 2019, according to a 2021 report from the nonpartisan Congressional Budget Office (CBO). The median cost to develop one drug was $900 million, with... View Details
    Keywords: by Kasandra Brabaw; Pharmaceutical
    • 01 Mar 2004
    • News

    Drug Imports a Hot Topic at Alumni Health-Care Conference

    between the high cost of developing prescription drugs and patient demand for lower prices. Speaking on “The Politics of Innovation,” McClellan acknowledged that many patients... View Details
    Keywords: Colleges, Universities, and Professional Schools; Educational Services
    • 11 Sep 2019
    • Research & Ideas

    Germany May Have the Answer for Reducing Drug Prices

    American lawmakers attempting to stem spiraling drug costs might find inspiration in Germany, where the government’s regulatory model has been curbing price growth without thwarting innovation or access,... View Details
    Keywords: by Danielle Kost; Health
    • 01 Mar 2007
    • News

    Daniel Vasella

    years” in a Financial Times poll of 4,000 executives. He recently spoke about the public policy and business challenges ahead. U.S. consumers complain loudly that prescription drugs View Details
    Keywords: Roger Thompson; multinational pharmaceutical company; prescription drugs; vaccines; Medicare; generics business; Health, Social Assistance
    • April 2024 (Revised July 2024)
    • Case

    Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs

    By: Joseph L. Badaracco, Tom Quinn and John Schultz
    Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details
    Keywords: Cost vs Benefits; Decisions; Judgments; Values and Beliefs; Global Strategy; Health Care and Treatment; Patents; Growth and Development Strategy; Growth Management; Product Positioning; Supply and Industry; Supply Chain; Corporate Social Responsibility and Impact; Mission and Purpose; Philanthropy and Charitable Giving; Opportunities; Social Issues; Equality and Inequality; Pharmaceutical Industry; Health Industry; Denmark; United States; Europe; China; India; Middle East; North Africa
    Related
    • 27 Feb 2019
    • Research & Ideas

    The Hidden Cost of a Product Recall

    American emissions tests. Volkswagen estimated that fines, repairs, and legal costs would total more than $30 billion. And worse, the company ceded its command of America’s diesel car market—producing more than one-third of the models... View Details
    Keywords: by Danielle Kost; Manufacturing; Consumer Products; Auto; Medical Devices & Supplies
    • Fast Answer

    Biotech and Pharmaceuticals: R&D spending, production cost

    can be found in company’s income statement that can be found in Capital IQ ABI/ProQuest - To locate articles on the topic, use search terms: drug development cost (drug development) AND (success... View Details
    • 26 Jan 2015
    • Research & Ideas

    National Health Costs Could Decrease if Managers Reduce Work Stress

    pressure, alcoholism, mental illness. Even so, the connections between job pressures and health—and what management can do to address the problem—have been little studied. “We have not placed a lot of emphasis on the role of workplace stress in the high View Details
    Keywords: by Michael Blanding; Health